Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Science Advances, 8, 3, S.
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2022
- Ereignis
-
Veröffentlichung
- (wer)
-
American Association for the Advancement of Science (AAAS)
- (wann)
-
2022
- Urheber
-
Krstic, Jelena
Reinisch, Isabel
Schindlmaier, Katharina
Galhuber, Markus
Riahi, Zina
Berger, Natascha
Kupper, Nadja
Moyschewitz, Elisabeth
Auer, Martina
Michenthaler, Helene
Nössing, Christoph
Depaoli, Maria R.
Ramadani-Muja, Jeta
Usluer, Sinem
Stryeck, Sarah
Pichler, Martin
Rinner, Beate
Deutsch, Alexander J. A.
Reinisch, Andreas
Madl, Tobias
Chiozzi, Riccardo Zenezini
Heck, Albert J. R.
Huch, Meritxell
Malli, Roland
Prokesch, Andreas
- DOI
-
10.1126/sciadv.abh2635
- URN
-
urn:nbn:de:bvb:384-opus4-1014888
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:55 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Krstic, Jelena
- Reinisch, Isabel
- Schindlmaier, Katharina
- Galhuber, Markus
- Riahi, Zina
- Berger, Natascha
- Kupper, Nadja
- Moyschewitz, Elisabeth
- Auer, Martina
- Michenthaler, Helene
- Nössing, Christoph
- Depaoli, Maria R.
- Ramadani-Muja, Jeta
- Usluer, Sinem
- Stryeck, Sarah
- Pichler, Martin
- Rinner, Beate
- Deutsch, Alexander J. A.
- Reinisch, Andreas
- Madl, Tobias
- Chiozzi, Riccardo Zenezini
- Heck, Albert J. R.
- Huch, Meritxell
- Malli, Roland
- Prokesch, Andreas
- Universität Augsburg
- American Association for the Advancement of Science (AAAS)
Entstanden
- 2022
Ähnliche Objekte (12)
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Multi-omics in prognosis of hepatocellular carcinoma
Intermittent Fasting Primes the Tumor Microenvironment and Improves Nanomedicine Delivery in Hepatocellular Carcinoma
Best of ASCO 2022: bladder cancer
Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
RNA-binding proteins as important regulators of long non-coding RNAs in cancer
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Multi-omics in prognosis of hepatocellular carcinoma
Intermittent Fasting Primes the Tumor Microenvironment and Improves Nanomedicine Delivery in Hepatocellular Carcinoma
Best of ASCO 2022: bladder cancer
Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
RNA-binding proteins as important regulators of long non-coding RNAs in cancer
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Multi-omics in prognosis of hepatocellular carcinoma
Intermittent Fasting Primes the Tumor Microenvironment and Improves Nanomedicine Delivery in Hepatocellular Carcinoma
Best of ASCO 2022: bladder cancer
Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?